Auxilium's stock price plummets after company lowers sales forecast

Auxilium Pharmaceuticals Inc.’s stock price plunged by nearly 20 percent Wednesday after the company lowered its revenue and income estimates for 2014, primarily because of lower-than-expected revenues from its Testim testosterone gel product...